Company Filing History:
Years Active: 1996
Title: George Seibel: Innovator in Pharmaceutical Selection Methods
Introduction
George Seibel is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals through his innovative methods for selecting pharmacologically active compounds. His work is particularly relevant in the development of treatments for various medical conditions.
Latest Patents
George Seibel holds a patent for a selection method for pharmacologically active compounds. This invention provides a predictive method for selecting organic compounds that exhibit useful pharmaceutical activity in mammals. The method utilizes volume areas of similar molecules to determine the potential effectiveness of compounds. When specific substituents of the test compound meet predetermined volume criteria, the compound undergoes a binding assay. Only compounds that pass this assay are recommended for further pharmaceutical evaluation. The patent includes example compounds, specifically derivatives of 4-substituted 2,6-diiodophenols, which have shown promise in treating conditions such as hyperthyroidism, angina pectoris, and arrhythmia.
Career Highlights
George Seibel is affiliated with the University of California, where he continues to advance research in pharmaceutical sciences. His innovative approach to compound selection has the potential to streamline the drug development process and improve therapeutic outcomes.
Collaborations
Throughout his career, George has collaborated with esteemed colleagues, including Thomas N. Lavin and Mark F. Norman. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical methodologies.
Conclusion
George Seibel's contributions to the field of pharmaceuticals through his innovative selection methods highlight the importance of research in developing effective treatments. His work continues to influence the pharmaceutical industry and improve patient care.